257 related articles for article (PubMed ID: 11573859)
1. Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery.
Erstad BL
Ann Pharmacother; 2001 Sep; 35(9):1075-84. PubMed ID: 11573859
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
3. Systemic hemostatic medications for reducing surgical blood loss.
Erstad BL
Ann Pharmacother; 2001; 35(7-8):925-34. PubMed ID: 11485146
[TBL] [Abstract][Full Text] [Related]
4. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
6. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW
Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875
[TBL] [Abstract][Full Text] [Related]
7. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
Henry D; Carless P; Fergusson D; Laupacis A
CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
[TBL] [Abstract][Full Text] [Related]
8. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
Carless PA; Moxey AJ; Stokes BJ; Henry DA
BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
10. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis.
Abrishami A; Chung F; Wong J
Can J Anaesth; 2009 Mar; 56(3):202-12. PubMed ID: 19247741
[TBL] [Abstract][Full Text] [Related]
11. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
12. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
13. [Hemostatic management for cardiac surgical patients in the post-aprotinin era].
Tanaka K
Masui; 2009 Mar; 58(3):288-97. PubMed ID: 19306629
[TBL] [Abstract][Full Text] [Related]
14. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
[TBL] [Abstract][Full Text] [Related]
16. Cost/benefit analysis of pharmacologic hemostasis.
Harmon DE
Ann Thorac Surg; 1996 Feb; 61(2 Suppl):S21-5; discussion S33-4. PubMed ID: 8572828
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient.
Ozier Y; Schlumberger S
Can J Anaesth; 2006 Jun; 53(6 Suppl):S21-9. PubMed ID: 16766788
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.
Porte RJ; Leebeek FW
Drugs; 2002; 62(15):2193-211. PubMed ID: 12381219
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
